A ABBV

Abbvie Inc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

AbbVie Inc is a prominent American biopharmaceutical firm, founded in 2013 as a spin-off from Abbott Laboratories, dedicated to the research, development, and commercialization of cutting-edge therapies across immunology, oncology, virology, and neuroscience. Renowned for its flagship immunology pro...

$224.69

-0.98% ($2.23)

Volume 5.33M

52W High $244.81

52W Low $159.01

Market Cap $306.02B

← Back to Calendar Compare with Others →

What to Watch This Quarter

Based on historical data

Consensus EPS

$3.01

Whisper EPS

$2.85

5.4% below consensus

Last Quarter

$2.71

Current Streak

2 Misss

Avg Surprise (4Q)

-20.05%

Next Earnings Report

Reports in 53 days

Report Date Apr 23, 2026

Whisper Spread -5.41%

Consensus Estimate

$3.01

Official analyst average

Whisper Number

$2.85

What traders expect

Cautious Sentiment: The whisper number is 5.4% below consensus, suggesting traders are skeptical. Meeting consensus may not be enough to satisfy the market.

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q4 2025 Feb 4, 2026

1-Day: +0.88%

5-Day: +2.83%

Q3 2025 Nov 5, 2025

1-Day: +1.05%

5-Day: +0.89%

Q2 2025 Jul 31, 2025

1-Day: +3.28%

5-Day: +5.04%

Q1 2025 Apr 25, 2025

5-Day: +4.86%

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q4 2025	Feb 4, 2026	$3.35	$3.31	$2.71	-19.10%	Missed
Q3 2025	Nov 5, 2025	$3.27	$3.35	$1.86	-43.12%	Missed
Q2 2025	Jul 31, 2025	$2.91	$3.02	$2.97	+2.06%	Missed
Q1 2025	Apr 25, 2025	$2.40	$2.47	$2.46	+2.50%	Met
Q4 2024	Jan 31, 2025	$2.12	$2.20	$2.16	+1.89%	Missed
Q3 2024	Oct 30, 2024	$2.92	$3.01	$3.00	+2.74%	Met
Q2 2024	Jul 25, 2024	$2.57	$2.65	$2.65	+3.11%	Met
Q1 2024	Apr 26, 2024	$2.23	$2.31	$2.31	+3.59%	Met
Q4 2023	Feb 2, 2024	$2.77	$2.84	$2.79	+0.72%	Missed
Q3 2023	Oct 27, 2023	$2.86	$2.95	$2.95	+3.15%	Met
Q2 2023	Jul 27, 2023	$2.81	$2.87	$2.91	+3.56%	Beat
Q1 2023	Apr 27, 2023	$2.46	$2.53	$2.46	+0.00%	Missed